California | 001-36743 | 94-2404110 | ||||||||||||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class |
Trading symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, $0.00001 par value per share | AAPL | The Nasdaq Stock Market LLC | ||||||
0.000% Notes due 2025 | — | The Nasdaq Stock Market LLC | ||||||
0.875% Notes due 2025 | — | The Nasdaq Stock Market LLC | ||||||
1.625% Notes due 2026 | — | The Nasdaq Stock Market LLC | ||||||
2.000% Notes due 2027 | — | The Nasdaq Stock Market LLC | ||||||
1.375% Notes due 2029 | — | The Nasdaq Stock Market LLC | ||||||
3.050% Notes due 2029 | — | The Nasdaq Stock Market LLC | ||||||
0.500% Notes due 2031 | — | The Nasdaq Stock Market LLC | ||||||
3.600% Notes due 2042 | — | The Nasdaq Stock Market LLC |
Exhibit Number |
Exhibit Description | |||||||
99.1 | ||||||||
104 | Inline XBRL for the cover page of this Current Report on Form 8-K. |
Date: | January 30, 2025 | Apple Inc. | |||||||||||||||
By: | /s/ Kevan Parekh | ||||||||||||||||
Kevan Parekh | |||||||||||||||||
Senior Vice President, Chief Financial Officer |
Three Months Ended | |||||||||||
December 28, 2024 |
December 30, 2023 |
||||||||||
Net sales: | |||||||||||
Products | $ | 97,960 | $ | 96,458 | |||||||
Services | 26,340 | 23,117 | |||||||||
Total net sales (1) |
124,300 | 119,575 | |||||||||
Cost of sales: | |||||||||||
Products | 59,447 | 58,440 | |||||||||
Services | 6,578 | 6,280 | |||||||||
Total cost of sales | 66,025 | 64,720 | |||||||||
Gross margin | 58,275 | 54,855 | |||||||||
Operating expenses: |
|||||||||||
Research and development |
8,268 | 7,696 | |||||||||
Selling, general and administrative |
7,175 | 6,786 | |||||||||
Total operating expenses |
15,443 | 14,482 | |||||||||
Operating income |
42,832 | 40,373 | |||||||||
Other income/(expense), net |
(248) | (50) | |||||||||
Income before provision for income taxes |
42,584 | 40,323 | |||||||||
Provision for income taxes |
6,254 | 6,407 | |||||||||
Net income |
$ | 36,330 | $ | 33,916 | |||||||
Earnings per share: |
|||||||||||
Basic |
$ | 2.41 | $ | 2.19 | |||||||
Diluted |
$ | 2.40 | $ | 2.18 | |||||||
Shares used in computing earnings per share: |
|||||||||||
Basic |
15,081,724 | 15,509,763 | |||||||||
Diluted |
15,150,865 | 15,576,641 | |||||||||
(1) Net sales by reportable segment: |
|||||||||||
Americas |
$ | 52,648 | $ | 50,430 | |||||||
Europe |
33,861 | 30,397 | |||||||||
Greater China |
18,513 | 20,819 | |||||||||
Japan |
8,987 | 7,767 | |||||||||
Rest of Asia Pacific |
10,291 | 10,162 | |||||||||
Total net sales |
$ | 124,300 | $ | 119,575 | |||||||
(1) Net sales by category: |
|||||||||||
iPhone |
$ | 69,138 | $ | 69,702 | |||||||
Mac |
8,987 | 7,780 | |||||||||
iPad |
8,088 | 7,023 | |||||||||
Wearables, Home and Accessories |
11,747 | 11,953 | |||||||||
Services |
26,340 | 23,117 | |||||||||
Total net sales |
$ | 124,300 | $ | 119,575 |
December 28, 2024 |
September 28, 2024 |
||||||||||
ASSETS: | |||||||||||
Current assets: |
|||||||||||
Cash and cash equivalents |
$ | 30,299 | $ | 29,943 | |||||||
Marketable securities |
23,476 | 35,228 | |||||||||
Accounts receivable, net |
29,639 | 33,410 | |||||||||
Vendor non-trade receivables |
29,667 | 32,833 | |||||||||
Inventories |
6,911 | 7,286 | |||||||||
Other current assets |
13,248 | 14,287 | |||||||||
Total current assets |
133,240 | 152,987 | |||||||||
Non-current assets: |
|||||||||||
Marketable securities |
87,593 | 91,479 | |||||||||
Property, plant and equipment, net |
46,069 | 45,680 | |||||||||
Other non-current assets |
77,183 | 74,834 | |||||||||
Total non-current assets |
210,845 | 211,993 | |||||||||
Total assets |
$ | 344,085 | $ | 364,980 | |||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY: | |||||||||||
Current liabilities: |
|||||||||||
Accounts payable |
$ | 61,910 | $ | 68,960 | |||||||
Other current liabilities |
61,151 | 78,304 | |||||||||
Deferred revenue |
8,461 | 8,249 | |||||||||
Commercial paper |
1,995 | 9,967 | |||||||||
Term debt |
10,848 | 10,912 | |||||||||
Total current liabilities |
144,365 | 176,392 | |||||||||
Non-current liabilities: |
|||||||||||
Term debt |
83,956 | 85,750 | |||||||||
Other non-current liabilities |
49,006 | 45,888 | |||||||||
Total non-current liabilities |
132,962 | 131,638 | |||||||||
Total liabilities |
277,327 | 308,030 | |||||||||
Commitments and contingencies |
|||||||||||
Shareholders’ equity: |
|||||||||||
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,040,731 and 15,116,786 shares issued and outstanding, respectively |
84,768 | 83,276 | |||||||||
Accumulated deficit | (11,221) | (19,154) | |||||||||
Accumulated other comprehensive loss | (6,789) | (7,172) | |||||||||
Total shareholders’ equity |
66,758 | 56,950 | |||||||||
Total liabilities and shareholders’ equity |
$ | 344,085 | $ | 364,980 |
Three Months Ended | |||||||||||
December 28, 2024 |
December 30, 2023 |
||||||||||
Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances | $ | 29,943 | $ | 30,737 | |||||||
Operating activities: | |||||||||||
Net income | 36,330 | 33,916 | |||||||||
Adjustments to reconcile net income to cash generated by operating activities: | |||||||||||
Depreciation and amortization | 3,080 | 2,848 | |||||||||
Share-based compensation expense | 3,286 | 2,997 | |||||||||
Other | (2,009) | (989) | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable, net | 3,597 | 6,555 | |||||||||
Vendor non-trade receivables | 3,166 | 4,569 | |||||||||
Inventories | 215 | (137) | |||||||||
Other current and non-current assets | 939 | (1,457) | |||||||||
Accounts payable | (6,671) | (4,542) | |||||||||
Other current and non-current liabilities | (11,998) | (3,865) | |||||||||
Cash generated by operating activities | 29,935 | 39,895 | |||||||||
Investing activities: | |||||||||||
Purchases of marketable securities | (6,124) | (9,780) | |||||||||
Proceeds from maturities of marketable securities | 15,967 | 13,046 | |||||||||
Proceeds from sales of marketable securities | 3,492 | 1,337 | |||||||||
Payments for acquisition of property, plant and equipment | (2,940) | (2,392) | |||||||||
Other | (603) | (284) | |||||||||
Cash generated by investing activities | 9,792 | 1,927 | |||||||||
Financing activities: | |||||||||||
Payments for taxes related to net share settlement of equity awards | (2,921) | (2,591) | |||||||||
Payments for dividends and dividend equivalents | (3,856) | (3,825) | |||||||||
Repurchases of common stock | (23,606) | (20,139) | |||||||||
Repayments of term debt | (1,009) | — | |||||||||
Repayments of commercial paper, net | (7,944) | (3,984) | |||||||||
Other | (35) | (46) | |||||||||
Cash used in financing activities | (39,371) | (30,585) | |||||||||
Increase in cash, cash equivalents, and restricted cash and cash equivalents | 356 | 11,237 | |||||||||
Cash, cash equivalents, and restricted cash and cash equivalents, ending balances | $ | 30,299 | $ | 41,974 | |||||||
Supplemental cash flow disclosure: | |||||||||||
Cash paid for income taxes, net | $ | 18,651 | $ | 7,255 |